Publications & Media / Publications & médias
The 14th annual CARE™ at ASH Meeting took place on December 6th 2019 in Orlando, Florida and was the largest to date with over 120 registered physicians and trainees. At...
The American College of Rheumatology/Association of Rheumatology Professionals (ACR/ARP) annual meeting took place on November 8th - 13th in Atlanta, Georgia. The conference featured a robust educational program, with over...
Select members of the CARE™ Gastroenterology Faculty attended the United European Gastroenterology: Week (UEGW) held in Barcelona, Spain from October 19th-23rd, 2019, as well as the American College of Gastroenterology...
2018 and 2019 have seen numerous data updates and news that could affect the management of prostate cancer (PC) in Canada. The CARE™ Genitourinary (GU) Faculty focuses on framing potentially...
Members of the CARE™ Hematology Faculty recently participated in the 2019 CCMDS/AML 2019 event on September 20th and 21st 2019 in Vancouver, British Columbia. The annual Canadian Conference on Myelodysplastic...
There have been significant changes in the CLL treatment landscape with the approval of novel targeted therapies and greater understanding of how molecular and mutation status can guide treatment decisions....
CLL is a rapidly evolving field. Recent drug approvals and updates in optimal management strategies have prompted the CARE™ Faculty to focus education efforts on practical application and impact on...
CARE™ Faculty most recently met with representatives from government, HTAs, public and private payers, and patient groups on September 19th, 2019 during the annual CARE™ Summit. The purpose of this...
The 9th Annual Canadian Hematology Conference (CHC) took place on September 20th and 21st 2019 in Toronto, Ontario. More than 20 Canadian and international opinion leaders presented to over 150...
There have been significant changes in the CLL treatment landscape with the approval of novel targeted therapies and greater understanding of how molecular and mutation status can guide treatment decisions....
